Delphi Genetics - Press releases

My Account

Notice: Undefined index: paysid in /homez.38/delphige/www/modeles/standard/commons/identificationBox.php on line 48

Change your country

Cart

Your Shopping Cart is empty.

Order on-line

News

The new DNAVAC research project targets the removal of antibiotics in veterinary DNA-vaccines
The new DNAVAC research project targets the removal of antibiotics in veterinary

Delphi Genetics participation to the AMERE study granted by the European Space Agency (ESA)
Nivelles, Belgium, 23rd of January 2012 – Lambda-X, Delphi Genetics, The d

Delphi Genetics at Peptalk 2012
Delphi Genetics will be present at the Peptalk meeting taking place in San

Delphi Genetics announces that all the bacterial strains present in its research kits are completely
Yokohama, Japan, 16 of December 2011 - Delphi Genetics announced today during a

New Products

You are here : About us > Press releases

< previous

next >

Delphi Genetics SA obtained the ISO 9001:2008 certification

13 Jan 2010

Delphi Genetics SA obtained the ISO 9001:2008 certification, confirming the company’s high standards of quality in customer services delivery and research kits production.

ISO9001

Charleroi, Belgium, 13^th January 2010.

Delphi Genetics, the company developing innovative tools and technologies for genetic engineering, announces today that it received recently the ISO9001:2008 certification, demonstrating its high standards of quality in providing DNA engineering customer services and innovative research kits. Through this new development, Delphi Genetics confirms its position as a reliable, innovative and organized business partner.

The ISO 9001:2008 standard specifies Quality Management System (QMS) requirements regarding an organization's ability to improve upon their products and services quality. In the course of the certification process, Delphi Genetics proved it had implemented the necessary standards and procedures to regularly, quantifiably and verifiably deliver quality products and customer services, while applying a systematic approach towards overall quality management.

"Since the ISO certification is only obtained after a thorough analysis by an independent authority, it stands as a recognition of Delphi Genetics’ excellence in providing its customers and business partners with quality products and tailor-made services. This certification highlights the management quality of a company thriving on an outstanding innovative spirit", said Philippe Gabant, Delphi Genetics CEO.

Recently, Delphi Genetics announced a licensing agreement with Sanofi Pasteur for the use of its antibiotic-free Staby® technology for the production of human recombinant vaccines.